4xyx
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ''' | + | ==NanB plus Optactamide== |
| - | + | <StructureSection load='4xyx' size='340' side='right' caption='[[4xyx]], [[Resolution|resolution]] 2.10Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[4xyx]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XYX OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4XYX FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=43Z:OPTACTAMIDE'>43Z</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | |
| - | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Exo-alpha-sialidase Exo-alpha-sialidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.18 3.2.1.18] </span></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4xyx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xyx OCA], [http://pdbe.org/4xyx PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4xyx RCSB], [http://www.ebi.ac.uk/pdbsum/4xyx PDBsum]</span></td></tr> | |
| - | [[ | + | </table> |
| - | [[Category: | + | __TOC__ |
| + | </StructureSection> | ||
| + | [[Category: Exo-alpha-sialidase]] | ||
[[Category: Brear, P]] | [[Category: Brear, P]] | ||
| - | [[Category: Rogers, G | + | [[Category: Rogers, G W]] |
| + | [[Category: Taylor, G L]] | ||
| + | [[Category: Westwood, N J]] | ||
[[Category: Yang, L]] | [[Category: Yang, L]] | ||
| - | [[Category: | + | [[Category: Hydrolase]] |
| + | [[Category: Inhibitor binding]] | ||
Revision as of 17:22, 10 February 2016
NanB plus Optactamide
| |||||||||||
